Cytokine expression profile in COVID-19 oropharyngeal/nasopharyngeal swabs

Cytokine expression profile in COVID-19 oropharyngeal/nasopharyngeal swabs

Cytokine expression profile in COVID-19 oropharyngeal/nasopharyngeal swabs


Dr. Mir Munir Rahim

University of Windsor

Approximately, 15% of confirmed coronavirus disease-19 (COVID-19) patients develop a severe disease, leading to complications including pneumonia, acute respiratory distress syndrome, respiratory failure, shock, organ failure and potentially death. The leading mediators of lung injury in COVID-19 patients are the pro-inflammatory cytokines produced during virus infection in the lungs. Therefore, early detection of pro-inflammatory cytokines in confirmed COVID-19 patients could provide important information about disease progression and inform appropriate early intervention. The overall goal of this project is to determine the type and levels of pro-inflammatory cytokines in oropharyngeal swabs taken from suspected COVID-19 patients.

Related Programs:
Nucleus Cores:

FUNDER:

WE-SPARK Health Institute and Office of Research and Innovation Services, University of Windsor

GRANT DURATION:

2020-2021

CO-APPLICANTS:

University of Windsor

  • Dr. Lisa Porter

  • Dr. Yufeng Tong

Windsor Regional Hospital

  • Dr. Caroline Hamm

S.M. Research Inc.

  • Dr. Enders Ng

Loading...